Cytovia Therapeutics
Dr. Rath has extensive experience in general management, sales and marketing, medical affairs, and market access. He has held the positions of Managing Director for Shionogi in Germany and Spain, General Manager for Germany at Archimedes Pharma – a private equity backed company – and Business Unit Director with full P&L responsibility at Baxter.
This person is not in any offices
Cytovia Therapeutics
2 followers
Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing several of the most challenging unmet medical needs including the prevention of cancer relapse and metastasis. Cytovia focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including allogeneic cell therapy, multispecific antibodies, and cytokines. Cytovia establishes development partnerships to accelerate time-to-market and commercialization alliances in order to optimize rapid adoption of its novel immunotherapies.